Curriculum Vitae

    Published Abstracts:
  1. Patak RV, Fadem SZ, Mauk RH, Lifschitz MD, and Stein JH. Attenuation of norepinephrine induced acute renal failure by renal vasodilatation. Kidney International 10:564, 1976
  2. Patak RV, Fadem SZ, Lifschitz MD, and Stein JH. The effect of diuretics on the initial phase of norepinephrine induced acute renal failure in the dog. Clinical Research 25:444A, 1977
  3. Patak RV, Fadem SZ, Lifschitz MD, and Stein JH. Studies on the mechanism of increased sodium excretion during drug induced vasodilatation. Kidney International 12:557, 1977
  4. Patak R, Rosenblatt S, Fadem S, Lifschitz M, and Stein J. Diuretic induced changes in renal prostagladin excretion. Kidney International 12:506, 1977
  5. Rosenblatt S, Lifschitz M, Welch R, Fadem S, and Stein J. Gastrointestinal blood loss and iron deficiency in patients on chronic hemodialysis. Kidney International 12:488m, 1977
  6. Lifschitz MD, Patak RV, Fadem SZ, and Stein JH. Chronic changes in renal sodium excretion and renal prostaglandin E production in the rabbit. Clinical Research 26:64A, 1978
  7. Patak R, Fadem S, Rosenblatt S, Lifschitz M, and Stein JH. Diuretic induced changes in renal prostaglandin E excretion. Clinical research 26:42A, 1978
  8. Schaefer PC, Fadem SZ, Lifschitz M, and Goldsmith RS. Hypercalcemia due to high serum dihydroxycholecalciferol (1,25-DHCC). Clinical Research 26:522A, 1978
  9. Schaefer PC, Lifschitz M, Fadem SZ, and Goldsmith RS. Radioimmunoassay of 1,25-dihydroxycholecaliciferol in patients with renal diseases. Endocrine Society, 1978
  10. Cabala D, Winkle S, Poindexter S, Hedberg AM, Fadem S.Implementation of an education program for nutrient/drug education. American Society of Parenteral & Enteral Nutrition. 14th Clinical congress, 1990, San Antonio, Texas
  11. Tuma SN, Fadem SZ, Suki WN. Most severe alkalosis in human (ph 7.98), resulting in cardiac arrest. Successful outcome after hemodialysis and IV HCI. 11th International Congress of Nephrology, 1990.
  12. S. Noor Rahman, K.J. Heifner, S.Z. Fadem, M.E. McIovr, R.M. Brenner, K.M.Powers, J.M. Ford; "Health Related Quality of Life (HRQOL) Improvements in Anemic Chronic Kidney Disease (CKD) Patients Treated with Darbepoetin Alfa (AranespTM)"; 2002 National Kidney Foundation (NKF) Clinical Nephrology Meetings, April 2002. (Chicago, IL).
  13. S. Noor Rahman, K.J. Heifner, S.Z. Fadem, M.E. McIovr, R.M. Brenner, K.M. Powers, J.M. Ford; "Treatment of Anaemia with AranespTM (Darbepoetin Alfa) Improves Health Related Quality of Life (HRQOL) in Patients with Chronic Kidney Disease (CKD)"; 39th Annual Meeting of the European Renal Associations (ERA) / European Dialysis and Transplantation Association (EDTA) Meetings, July 2002 (Copenhagen, DENMARK).
  14. Lawrence M. Spergel, Janet E. Holland, Stephen Z. Fadem, Charles J. McAllister, Eileen J. Peacock; "Elevated Static Intra-Access Pressure Ratio (IAPR) is not Indicative of Low Access Blood Flow (AF)"; J Am Soc Nephrol 14:53A, 2003.
  15. P. Qiu, O. Smolenski, S. Fadem, K.S. Kant, L. Borneman, R. Hippensteel, L.A., Williams, S. Moe, "Rapid Control of Secondary Hyperparathyroidism with Paracalcitol (Zemplar®) Capsule in Patients on Peritoneal Dialysis"; J Am Soc Nephrol 14:484A, 2003.
  16. Daniel Coyne, k.J. Martin, P. Qiu, M. Acharya, D. Batlle, S. Rosansky, H. Abboud, S. Fadem, L. Levine, O. Smolenski, M. Kaplan, L. Williams, S. Sprague."Paricalcitol (Zemplar®) Capsule Controls Secondary Hyperparathyroidism (SHPT) in Chronic Kidney Disease (CKD) Stages 3 and 4 Patients"; J Am Soc Nephrol 15:733A, 2004.
  17. DeAnna Cheek, I. Teitelbaum, E. Zawada, D. Echlin, L. Williams, S. Fadem. "Paricalcitol (Zemplar®) Capsule Reduced Elevated iPTH Levels Significantly in CKD Stages 3 and 4 Patients Regardless of Race, Gender, Age, Disease Severity and Diabetic Status." J Am Soc Nephrol 15:734A, 2004.
    Publications:
  1. Allen JR, Fadem SZ, Schecter MP, Toussleng PV, and Lester B. Paseo Drug Rap, Paseo Center, 1972 (A monograph on drug abuse among teenagers).
  2. Vineyard GC, Fadem SZ, Drmochowskia J, Carpenter CB, and Wilson RE.Evaluation of corticosteroid therapy for acute renal allograft rejection. Surgery, Gynecology, and Obstetrics 138:229, 1974
  3. Mauk RH, Patak RV, Fadem SZ, Lifschitz MD, and Stein JH. Effect of prostaglandin E administration in a nephrotoxic and a vasoconstrictor model of acute renal failure. Kidney International 12:122-130, 1977
  4. Stein JH and Fadem SZ. The renal circulation. J.A.M.A 239:1308-1312, 1978
  5. Lifschitz MD, Patak RV, Fadem SZ, and Stein JH. Urinary prostaglandin E excretion: Effect of chronic alterations in sodium intake and inhibition of prostaglandin synthesis in the rabbit. Prostaglandins 16:607-619,1978.
  6. Patak RV, Fadem SZ, Lifschitz MD, and Stein JH. A study of factors which modify the development of norepinephrine induced acute renal failure in the dog. Kidney International15:227-237, 1979
  7. Patak RV, Fadem SZ, Lifschitz MD, and Stein JH. Diuretic-induced changes in renal blood flow and prostaglandin E excretion in the dog. Am J Physiol 236:F494-F500, 1979
  8. Sack KE, Bekheit S, Fadem SZ, and Vedrossian CW. Severe pulmonary vascular disease in systemic lupus erythematosus. Southern Medical Journal 72:1016-1018, 1979
  9. Fadem SZ and Lifschitz DM. Use of saralasin in end stage renal disease. Kidney International Supplement s93-S100, 1979
  10. Bardgette JJ and Fadem SZ. Multiple myeloma. The Science and Practice of Clinical Medicine, Vol VI. John Dietschy, Sr. (Editor) Grune and Stratton.1980, 343-344
  11. Fadem SZ and Lifschitz MD. Macroglobulinemia. The Science and Practice of Clinical Medicine, Vol VI. John Dietschy, Sr. (Editor) Grune and Stratton.1980, 343-344
  12. Lifschitz MD, Patak R, Fadem S, Rosenblatt S, Burns R, Epstein M, and Stein JH. Factors involved in the regulation of renal prostaglandin production. Prostaglandins in Cardiovascular and Renal Functions:: proceedings of the 20th annual A.N. Richards Symposium of the Physiological Society of Philadelphia. Alexander Scriabine, Allan M. Lefer And Frederick A. Kuehl, Jr (Editors) Spectrum Publications, 1980
  13. Fadem SZ, Hernandez-Llamas G, Patak RV, Rosenblatt SG, Lifschitz MD, and Stein JH. Studies on the mechanism of sodium excretion during drug-induced vasodilations in the dog. Journal of Clinical Investigation 69:604-610m 1982
  14. Rosenblatt SG, Drake S, Fadem S, Welch R, and Lifschitz MD.Gastrointestinal blood loss inpatients with chronic renal failure. American Journal of Kidney Diseases. 1:232-236, 1982
  15. Fadem SZ, Helping patients, renal staff gains access to information. Nephrology New and Issues, 12:38-9, 1998
  16. Fadem SZ, One Year Later. Peritoneal Diabetes International,19,509-11,1999
  17. Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warnock DG. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney International 61:1830-9, 2002
  18. Atef-Zafarmand A, Fadem S,Disaster nephrology: medical perspective. Adv Ren Replace Ther. 10104-16, 2003.
  19. Spergel LM, Holland JE, Fadem SZ, McAllister CJ, Peacock EJ.Static intra-access pressure ratio does not correlate with access blood flow. Kidney Int. 2004 Oct;66(4):1512-6.
  20. Fadem S.The need for computer-based patient education. Adv Chronic Kidney Dis. 12:335-8, 2005.
  21. Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, Fadem S, Levine B,Williams L, Andress DL, Sprague SM.Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47(2):263-6, 2006
  22. Fadem SZ. Chronic kidney disease as it relates to heart disease in the cancer patient. In: Ewer MS, ed. Cancer and the heart. St. Louis: Decker, B.C., 2006
  23. Fadem SZ and Moe SMManagement of chronic kidney disease mineral-bone disorder. Adv Chronic Kidney Dis. 14(1):44-53,2007
  24. Fadem SZ and Moe SM(Journal Guest Editor) Editorial: Management of chronic kidney disease-mineral bone disorder. Adv Chronic Kidney Dis. 14(1):2,2007.
  25. Fadem, SZ, Spry, L and Yee, J(Journal Guest editor) Editorial:Clinical Practice Management Issues. Adv Chronic Kidney Dise. 15(1):3-6, 2008.
  26. WIntz, R, Rosenthal, B and Fadem, SZThe Physician Quality Reporting Initiative: practical approach to implementing quality reporting. Adv Chronic Kidney Dis. 15(1):56-63, 2008.
  27. Buettner, K and Fadem, SZThe Internet as a tool for the renal community. Adv Chronic Kidney Dis. 15(1):73-82, 2008.
  28. Fadem, SZ, Internet Resources for Nephrologists, In: Wilcox, C. ed. Therapy in Nephrology and Hypertension: A companion to Brenner & Rector's: The Kidney, WB Saunders, New York 2008
  29. Fadem SZ, Al-Saghir F, Zollner G, Swan S. Converting hemodialysis patients from intravenous paricalcitol to intravenous doxercalciferol - a dose equivalency and titration study. Clin Nephrol. (4):319-24, 2008.
  30. Friedman A, FademS.Reassessment of Albumin as a Nutritional Marker in Kidney Disease. J Am Soc Nephrol.2010; 0: ASN.2009020213v1-ASN.2009020213 (online)
    Patient Education Articles:
  1. Fadem, Stephen Z.As someone recently diagnosed with CKD, can I swim and exercise? Kidney Beginnings,1,1:2002.
  2. Fadem, Stephen Z.,Garney, Paul, RD, Smith, Bruce T.As someone with chronic kidney disease, are there any herbal products that may cause further damage to the kidneys? aakpRenalife,17,6:2002.
  3. Fadem, Stephen Z.My doctor told me that controlling my kidney disease means controlling my blood pressure. What does this mean? Kidney Beginnings,1,1:2002.
  4. Fadem, Stephen Z.Keeping Fit: Why Dialysis Patients Should Exercise aakpRenalife,18,4:2003.
  5. Fadem, Stephen Z. Can I feel blood being pumped during hemodialysis? aakpRenalife,19,2:2003.
  6. Fadem, Stephen Z.,Garney, Paul, RD, Smith, Bruce T.Are Herbal Products Risky For Chronic Kidney Disease Patients? Kidney Beginnings,2,1,2003.
  7. Fadem, Stephen Z.Is there a connection between protein leakage and cholesterol level? Kidney Beginnings,3,1:2004.
  8. Fadem, Stephen Z.What medicines should I avoid now that I have reduced kidney function? Kidney Beginnings,3,2:2004.
  9. Fadem, Stephen Z.Just how does the kidney handle medications and what happens when kidney function is not optimal? Kidney Beginnings,3,2:2004.
  10. Fadem, Stephen Z.What is GFR? Kidney Beginnings,3,3:2004.
  11. Fadem, Stephen Z.My access is infected. Now what? aakpRenalife,20,2:2004.
  12. Fadem, Stephen Z.Delaying Dialysis: Managing Reduced Kidney Function aakpRenalife,20,3:2004.
  13. Fadem, Stephen Z.Can dialysis affect my vision? aakpRenalife,20,5:2005.
  14. Fadem, Stephen Z.Can aluminum antiperspirants harm me? aakpRenalife,21,1:2005.
  15. Fadem, Stephen Z.Slowing the Progression of Kidney Disease Kidney Beginnings, 4,3:2005.
  16. Fadem, Stephen Z.Understanding Anemia in Chronic Kidney Disease Kidney Beginnings, 4,5:2005.
  17. Fadem, Stephen Z.Can Over-the-Counter Medications be Dangerous if I am Also Taking Prescribed Medications? Kidney Beginnings, 5, 1, 2006.
  18. Fadem, Stephen Z.Preparation for Dialysis - The AV Fistula Kidney Beginnings, 6:5, 2007.
  19. Fadem, Stephen Z.Why does salt cause high blood pressure? aakp Renalife, 23,5:2007.
  20. Fadem, Stephen Z.The FDA Black Box Warning for ESAs aakp Renalife, 23,6:2007.
  21. Fadem, Stephen Z.A Doctor Gets Sick aakp Renalife, 23,12:2007.
  22. Fadem, Stephen Z. A Nephrologist as a Cancer Patient Finds Enlightenment in a Support Group, Kidney Times, January, 2008 - EasyLink Access #: 282
  23. Fadem, Stephen Z.Cover Story - Remembering Kris Robinson aakp Renalife, 25,4:2009
  24. Fadem, Stephen Z.Medicines that Help Slow the Progression of Kidney Disease Kidney Beginnings,5,9:2009
    Meetings Attended:
  1. American College of Physicians, National Meeting, San Francisco, 1975
  2. ACP-Post Graduate Course, Renal, Galveston, 1976
  3. American Heart Association, Post Graduate Course on Chronic Renal Failure, New Haven, 1977
  4. American College of Physicians, Post Graduate Course, Renal, San Antonio, 1977
  5. American Society of Nephrology, National Meeting, Washington, 1977
  6. American College of physicians, National Meeting, Boston, 1978
  7. American Society of Nephrology, National Meeting, New Orleans, 1978
  8. American Society of Nephrology, National Meeting, Washington, 1980
  9. American College of Physicians, National Meeting, Kansas City, 1981
  10. American Society of Nephrology, National Meeting, Chicago, 1982
  11. First International Congress on Cyclosporins, Houston, 1983
  12. American Society of Nephrology, National Meeting, Washington, 1983
  13. American Society of Nephrology, National Meeting, Washington, 1984
  14. American Society of Nephrology, National Meeting, Washington, 1986
  15. American Society of Nephrology, National Meeting, Washington, 1987
  16. Advanced Technical Symposium on Dialysis, Chicago, 1988
  17. PD Perspectives, Laguna Beach, 1988 American Society of Nephrology, National Meeting, San Antonio, 1988
  18. National Kidney Foundation, National Meeting, San Antonio, 1988
  19. Peritoneal Dialysis, National Meeting, Dallas, 1989
  20. Update 1989, National Kidney Foundation, Houston, 1989
  21. American Society of Nephrology, National Meeting, Washington, 1989
  22. National Kidney foundation, National Meeting, Washington, 1989
  23. Update 1991, National Kidney Foundation, Houston, 1991
  24. American Society of Nephrology, National Meeting, Baltimore, 1991
  25. National Kidney Foundation, National Meeting, Baltimore, 1991
  26. Peritoneal Dialysis, National Meeting, Seattle, 1992
  27. Update 1992, National Kidney Foundation, Houston
  28. National Kidney Foundation, National Meeting, Baltimore, 1992
  29. Health Care Under Clinton, Washington, 1993
  30. Update 1993, National Kidney Foundation, Houston
  31. American Society of Transplant Physicians, Houston, 1993
  32. Conference on Trauma and Renal Failure, Naharia, Israel, 1993
  33. International Congress of Nephrology, Jerusalem, 1993
  34. American Board of Quality Assurance and Utilization Review Physicians, Dallas, 1993
  35. ESRD Network 14 Meeting, Dallas, 1993
  36. National Kidney Foundation, Annual Meeting, Boston, 1993
  37. American Society of Nephrology, Annual Meeting, Boston, 1993
  38. National Kidney Foundation, Annual Meeting, Orlando, 1994
  39. American Society of Nephrology, Annual Meeting, Orlando, 1994
  40. International Congress of Nephrology, Madrid, 1995
  41. National Kidney Foundation, Annual Meeting, San Diego, 1995
  42. American Society of Nephrology, Annual Meeting, San Diego, 1995
  43. National Kidney Foundation, Spring Clinical Meeting, Anaheim, 1996
  44. National Kidney Foundation, Annual Meeting, New Orleans, 1996
  45. American Society of Nephrology, Annual Meeting, New Orleans, 1996
  46. National Kidney Foundation, Spring Clinical Meeting, Dallas, 1997
  47. ASAIO, Annual Meeting, Atlanta, 1997
  48. International Congress of Nephrology, Annual Meeting, Sydney, 1997
  49. Siggraph, Annual Meeting, Los Angeles, 1997
  50. National Kidney Foundation, Annual Meeting, San Antonio, 1997
  51. American Society of Nephrology, Annual Meeting, San Antonio, 1997
  52. National Kidney Foundation, Spring Clinical Meeting, Nashville, 1998
  53. ASAIO, Annual Meeting, New York City, 1998
  54. American Board of Quality Assurance and Utilization Review
  55. Physicians, Salt Lake City, October, 1999
  56. National Kidney Foundation, Annual Meeting, Miami Beach, Florida, 1999
  57. The Forum of ESRD Networks, National Meeting, Washington DC, 2000
  58. RPA, Annual Meeting, Washington DC, 2000
  59. National Kidney Foundation, Spring clinical Meeting, Atlanta, Georgia 2000
  60. Vascular Access for Hemodialysis, Biannual Symposium, San Antonio,Texas 2000
  61. American Society of Nephrology, Toronto, 2000
  62. RPA Annual Meeting, Washington DC, 2001
  63. National Kidney Foundation, Spring Clinical Meeting, 2001
  64. AAKP Annual Meeting, Memphis, Tennesee 2001
  65. American Society of Nephrology, San Francisco, California 2001
  66. International Society of Nephrology, San Francisco, California 2001
  67. International Foundation of Kidney Foundations, Los Angeles, California 2001
  68. Renal Physicians Association, Washington, D.C., 2002
  69. NKF Spring Clinical Meeting, Chicago, Illinois 2002
  70. AAKP Annual Meeting, Orlando, Florida 2002
  71. Sociedad Peruana de Nefrologia, Lima, Peru, 2002
  72. American Society of Nephrology, Philadelphia, Pennsylvania 2002
  73. Renal Physicians Association, Washington, D.C., 2003
  74. National Kidney Foundation, Spring Clinicals, 2003
  75. International Foundation of Kidney Foundations (IFKF), Amsterdam, 2003
  76. World Congress of Nephrology, International Society of Nephrology, Berlin, 2003
  77. American Association of Kidney Patients, New Orleans, Louisiana 2003
  78. American Society of Nephrology, San Diego, California 2003
  79. Renal Physicians Association, Baltimore, Maryland 2004
  80. National Kidney Foundation, Spring Clinicals, 2004
  81. International Foundation of Kidney Foundations, Adelaide, Australia 2004
  82. American Society of Nephrology, St. Louis, Missouri 2004
  83. AAKP Retreat, January, 2005
  84. Clinical Performance Measures Committee, Baltimore, Maryland 2005
  85. Be Active Board Ortho-Biotech, New York, New York 2005
  86. Renal Physicians Association, Washington, D.C., 2005
  87. National Kidney Foundation Spring Meeting, Washington, D.D., 2005
  88. American Association of Kidney Patients, Annual Meeting, Las Vegas, Nevada 2005
  89. American Society of Nephrology, Annual Meeting, Philadelphia, Pennsylvania November, 2005
  90. Renal Physicians Association, Baltimore, MD, 2006
  91. National Kidney Foundation, CM06, Baltimore, MD 2006
  92. International Federation of Kidney Foundations, Sicily 2006
  93. ERA-EDTA Annual Meeting, Glascow, Scotland, UK 2006
  94. International Society Peritoneal Dialysis, Annual Meeting, Hong Kong 2006
  95. American Association of Kidney Patients, Annual Meeting, Orlando, Florida 2006
  96. ASBMR (American Society of Bone and Mineral Research), Philadelphia, Pennsylvania 2006
  97. ASN, San Diego 2006
  98. Forum of ESRD Networks, Baltimore, 2007
  99. RPA Annual Meeting, Baltimore, 2007
  100. National Kidney Foundation, CM.07, Orlando, 2007
  101. IFKF 8th Annual Meeting, April 16-19, 2007 Curitiba, Brazil,
  102. World Congress of Nephrology, April 20-24, 2007, Rio de Jainero, Brazil
  103. Harvard Quality Colloquium, August 19-22, 2007, Cambridge, Massachusetts
  104. AAKP (American Association of Kidney Patients) Annual Meeting, August 30-September 2,2007, St. Louis, Missouri
  105. ASBMR (American Society of Bone and Mineral Research), Honolulu, Hawaii September 16-22, 2007
  106. ASN, San Francisco, 2007
  107. Forum of ESRD Networks, Baltimore, 2008
  108. RPA Annual Meeting, Austin, 2008
  109. AAKP Annual Meeting, Washington, DC, 2008
  110. ASN, Philadelphia, 2008
  111. RPA Annual Meeting, Baltimore, 2009
  112. NKF SCM09, Nashville, 2009
  113. Forum of ESRD Networks, Baltimore, 2009
    Selected Presentations:
  1. Fadem S, Patak R, Lifschitz M, and Stein J. Studies on the mechanism of increased sodium excretion during drug induced vasodilatation. (Presented at the American Society of Nephrology Annual Meeting, Washington, 1977).
  2. Solez K, Munoz Z, Daugirdas J, Fadem S. CyberNephrology, National kidney Foundation, Spring Clinical Meeting, Dallas, 1997
  3. Fadem SZ. Vanguards in Nephrology Poster Session, ASAIO, Atlanta, 1997
  4. Solez K, Fogo A, Daugirdas J, Fadem S. CyberNephrology, National Kidney Foundation, Spring Clinical Meeting, 1998
  5. Vanguards in Nephrology, ASAIO, New York, 1998
  6. Internet Security, DCA Computer Conference, Scottsdale, 1998
  7. Hepatitis in Developing Countries, Nepal, 1998
  8. History of Computing, Nepal, 1998
  9. Fadem SZ and Kim Solez, Internet Security, via Netmeeting, Paris, 1998
  10. Fadem SZ and Kim Solez, Issues in Nephrology - Netmeeting Transplant Pathology Conference 1998
  11. Fadem SZ and Kim Solez, Netmeeting - Philadelphia to Houston, 1998
  12. Diabetic Nephropathy, Texas Medical Association, 1999
  13. Internet, Discussion Group AAKP, Tampa, 2000
  14. Understanding the Internet, HCFA, Washington, 2000
  15. PreESRD, Medicine Grand Rounds, VAMC Houston, 2002
  16. Pre-ESRD Education AAKP, Memphis 2001
  17. In-credible web sites, AAKP, Memphis 2001
  18. Fadem SZ, Solez K, Hales M, Zelchezitz Conference, Dubai (via internet) 2001
  19. Chronic Kidney Disease, IFKF, Los Angeles, California, 2001
  20. Vascular Calcification, Medicine Grand Rounds, VAMC Houston, 2002
  21. S. Noor Rahman, K.J. Heifner, S.Z. Fadem, M.E. McIovr, R.M. Brenner, K.M Powers, J.M. Ford; "Health Related Quality of Life (HRQOL) Improvements in Anemic Chronic Kidney Disease (CKD) Patients Treated with Darbepoetin Alfa (AranespTM)"; 2002 National Kidney Foundation (NKF) Clinical Nephrology Meetings, April 2002 (Chicago, IL).
  22. Lessons from Africa, American Association of Kidney Patients,Orlando 2002
  23. Chemistries Workshop, American Association of Kidney Patients,Orlando 2002
  24. CKD Evaluation Workshop, American Association of Kidney Patients, Orlando 2002
  25. Preventing CKD, Sociedad de Nefrologia Peru, Lima, Peru 2002
  26. Reducing Mortality, Sociedad de Nefrologia Peru, Lima, Peru 2002
  27. Vascular Calcification, Sociedad de Nefrologia Peru, Lima, Peru 2002
  28. The Internet as a Patient Teaching Tool, Sociedad de Nefrologia Peru, Lima, Peru 2002
  29. Vascular Calcification - Baylor Renal Grand Rounds, Houston, Texas 2003
  30. Breakfast with the Experts, National Kidney Foundation Spring Clinicals, San Diego, California 2003
  31. Using the Internet to Develop Educational Resources for Kidney Foundations, IFKF, Amsterdam, 2003
  32. The Need for CKD Education Around the World, IFKF, Amsterdam, 2003
  33. Erythropoiesis for Nephrologists, Baylor Renal Grand Rounds, 2004
  34. Making the Internet Practical, IFKF, Adelaide, Australia, 2004
  35. Computer Magic - Renal Grand Rounds Baylor College of Medicine, Houston, Texas October 20, 2004
  36. Arrhythmia Management in ESRD and the Use of AEDs. ANNA Fall Seminar, San Antonio, Texas October, October 2004
  37. Information Systems to Monitor CKD Patient Management - Renal Physicians Association, Washington, DC March 20, 2005
  38. Fabry Disease - Baylor Renal Grand Rounds/Biopsy Conference - Baylor College of Medicine, 2005
  39. Alports Syndrome - Baylor Renal Grand Rounds/Biopsy Conference - Baylor College of Medicine, 2005
  40. Kidney Beginnings: Living withReduced Renal Function - AAKP National Conference - Workshop, Las Vegas, Nevada September 2,2005
  41. An Introduction to Reduced Renal Function - AAKP National Conference - Conference, Las Vegas, Nevada September 3,2005
  42. Get Connected: Kidney Disease on the Internet - AAKP National Conference - Workshop, Las Vegas, Nevada September 3,2005
  43. Electronic Health Records: Barriers, Reality, Implementation - Texas American Association of Clinical Endocrinologists, Houston, Texas September 17, 2005
  44. KDEC, Panel Moderator and Presenter Health Care policy Issues - Baltimore - October 26-29, 2006
  45. National Kidney Foundation of Southeast Texas, Fadem Update Symposium, Early CKD Management, A Social, Financial and Clinical Perspective, February 16, 2007, Houston
  46. Renal Physicians Association Annual Meeting, Nephrology Practice in the Information Age - How to Invest in IT without going Broke March 18-20, Baltimore2006
  47. Renal Physicians Association Annual Meeting, Nephrology Practice in the Information Age - Finding the Right System For Your Practice March 18-20, Baltimore2006
  48. Lunch with the Experts - AAKP 33rd Annual Meeting, Orlando August 31 - Sept 3,2006
  49. Lunch with the Experts - AAKP 33rd Annual Meeting, Orlando August 31 - Sept 3,2006
  50. Kidney Beginnings Live - AAKP 33rd Annual Meeting,Orlando August 31 - Sept 3,2006
  51. National Kidney Foundation Spring Clinical Meeting, CM.07 - Workshop: Technology and CKD - Benefits and Barriers of a System, April 13, 2007 - Orlando, Florida April 13, 2007
  52. National Kidney Foundation Spring Clinical Meeting, CM.07 - Computing Kidney Disease - Making the System Yours - Orlando, Florida April 13, 2007
  53. International Federation of Kidney Foundations Annual Meeting, - Using the Internet to Implement Patient Education Strategies -Curitiba, Brazil, April 7,2007
  54. Baylor College of Medicine, Houston, Texas - Renal Grand Rounds - May 23, 2007
  55. Brown Bag Lunch, Spring Branch Independent School District Corporate Offices, Houston, Texas CKD Awareness - August 29, 2007
  56. Directors of Physical Education, Spring Branch Independent School District - Butler Stadium, Creating a CKD Curriculum for Students - August 29, 2007
  57. Forum Conference, Houston, Texas - Introduction to Chronic Kidney Disease - October 9, 2007
  58. Baylor College of Medicine, Houston, Texas - Renal Grand Rounds - October 10, 2007
  59. Lunch with the Experts - AAKP 34th Annual Meeting, St Louis, Mo August 30,2007
  60. Lunch with the Experts - AAKP 34th Annual Meeting, St Louis, Mo August 31,2007
  61. Patient lecture - AAKP 34th Annual Meeting,St Louis, Mo September 1,2007
  62. Fact or Fiction - Dispelling Myths about Kidney Disease - AAKP 35th Annual Meeting, Washington, DC August 28, 2008
  63. Lunch with the Experts - The Connection Between Diabetes and Kidney Disease - AAKP 35th Annual Meeting, Washington, DC August 29,2008
  64. Lunch with the Experts - Chronic Kidney Disease - AAKP 35th Annual Meeting, Washington, DC August 30,2008
  65. Baylor College of Medicine, Houston, Texas - Renal Grand Rounds - From Genotype to Phenotype, MYH9 - January 21, 2009
  66. Renal Physicians Association, Satellite Breakfast Symposium, Moving Beyond the ESA Controversy, Baltimore, March 22,2009
  67. Renal Physicians Association, A Tribute to Robert Schrier, Medal of Excellence Dinner, Baltimore, March 22,2009
  68. National Kidney Foundation, SCM09, Dialysis Workshop, Nashville, March 25, 2009
  69. Why Do I Have Reduced Kidney Function? - AAKP 36th Annual Meeting, Denver, Co Sept 3,2009
  70. Lunch with the Experts - Cancer and Kidney disease - AAKP 36th Annual Meeting, Denver, Co August 31 - Sept 4,2009
  71. Lunch with the Experts - Understanding Restless Leg Syndrome - AAKP 36th Annual Meeting, Denver, Co August 31 - Sept 5,2009
    Research Experience:
  1. Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters 3&4: Genentech
  2. Anemia study: Comparing the Effect of C.E.R.A. and Epoetin Beta on Hemoglobin Response in Patients With Chronic Kidney Disease Who Are on Dialysis: Hoffmann-La Roche
  3. Sensipar (Cinacalcet HCl): Amgen (Evolve Study)
  4. Sulodexide in Diabetic Nephropathy: Keryx Biopharmaceuticals
  5. Ash Access: Ash Access Technology (Device Study)
  6. 3M: 3M Pharmaceutical (Device Study)
  7. GVAS: GraftCath Technology: Catheter (Device Study)
  8. GVAS: GraftCath Technology: Graft (Device Study)
  9. Lanthanum Carbonate: Shire.
  10. Sensipar. (Evolve) Amgen.
  11. Anemia with CKD not on Dialysis. Amgen.
  12. Hectrol Patient Registry. Bone Care International.
  13. Ferumoxytol in ESRD patients. Advanced Magnetics, Inc.
  14. Ferumoxytol in CKD Patients. Advanced Magnetics, Inc.
  15. Hypertension. Tarka. Abbott Laboratories.
  16. Hypercholesterolemia. Sharp. University of Oxford England: Merck
  17. Correct of Hemoglobin and Outcomes in Renal Insufficiency (Choir)